Title: Tardive Dystonia Associated With Ziprasidone
Abstract: Back to table of contents Previous article Next article Letter to the EditorFull AccessTardive Dystonia Associated With ZiprasidoneSPIRIDON PAPAPETROPOULOS, M.D., Ph.D., STEVE WHEELER, M.D., and CARLOS SINGER, M.D., SPIRIDON PAPAPETROPOULOS, M.D., Ph.D., STEVE WHEELER, M.D., and CARLOS SINGER, M.D., Miami, Fla.Published Online:1 Nov 2005https://doi.org/10.1176/appi.ajp.162.11.2191AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail To the Editor: Although the new atypical neuroleptics have held the promise of fewer extrapyramidal signs, there have been several reports of tardive movement disorders associated with their use. Ziprasidone-associated tardive dyskinesia has been rarely described (1). However, to our knowledge, there have been no reports of tardive dystonia caused by ziprasidone.Ms. A, a 56-year-old woman, was seen with a chief complaint of involuntary jaw movements. She had a 35-year history of migraines for which she had received a number of treatments (triptans, beta-blockers and calcium channel blockers, antiepileptics, antidepressants, and clonazepam) with limited success. Her first trial with an atypical neuroleptic was 2.5 years before her presentation, when she was administered ziprasidone (80 mg/day). Ms. A experienced a moderate decrease in the frequency and severity of her migraine attacks. Eleven months later, she started noticing mild involuntary movements of her tongue, and ziprasidone was gradually discontinued. Within 2 weeks, involuntary movements involving jaw opening were superimposed on the involuntary movements of her tongue. Gradually, her symptoms intensified, causing eating difficulties accompanied by weight loss (5–6 kg). She also experienced occasional tongue and oral mucosa injuries. Her past medical history was remarkable only for a hysterectomy performed for an ovarian cyst.A neurological examination revealed frequent, sustained jaw opening, with occasional tongue protrusions and rare dystonic furrowing of her eyebrows. No other abnormalities were noted; brain magnetic resonance imaging was normal. Ms. A had already received botulinum toxin type A injections without success and declined repeat injections.Tardive dystonia is a late-onset complication of treatment with dopamine-blocking agents consisting of persistent dystonic movements of focal onset involving mainly the craniocervical region. It usually appears while receiving a stable dose, but it may manifest while tapering the dose or even 1–3 weeks after discontinuation (as in our case) (2). In many patients, tardive dystonia is combined with the classic tardive oral-buccal-lingual dyskinesias (3). Tardive dystonia is very resistant to treatment and can occur in patients with psychiatric as well as other conditions (in our case, migraine headaches) (2). Although very rare, tardive dystonia has been reported with the use of other atypical neuroleptics, including clozapine, risperidone, and olanzapine (4).We found no reports of tardive dystonia occurring with ziprasidone on PubMed. Although our patient's clinical diagnosis was unequivocally tardive dystonia, with its time course consistent with ziprasidone monotherapy as the precipitant, the remote possibility of dystonia due to other causes (i.e., idiopathic, psychogenic) may be considered. Clinicians should keep in mind that there is no "absolutely safe" atypical neuroleptic since there is always a potential for the appearance of extrapyramidal signs.References1. Ananth J, Burgoyne KS, Niz D, Smith M: Tardive dyskinesia in 2 patients treated with ziprasidone. J Psychiatry Neurosci 2004; 29:467–469Medline, Google Scholar2. Kiriakakis V, Bhatia KP, Quinn NP, Marsden CD: The natural history of tardive dystonia: a long-term follow-up study of 107 cases. Brain 1998; 121(part 11):2053–2066Google Scholar3. Adityanjee, Aderibigbe YA, Jampala VC, Mathews T: The current status of tardive dystonia. Biol Psychiatry 1999; 45:715–730Crossref, Medline, Google Scholar4. Charfi F, Cohen D, Houeto JL, Soubrie C, Mazet P: Tardive dystonia induced by atypical neuroleptics: a case report with olanzapine. J Child Adolesc Psychopharmacol 2004; 14:149–152Crossref, Medline, Google Scholar FiguresReferencesCited byDetailsCited byThe Lancet Neurology, Vol. 15, No. 10Tardive Dyskinesia and Tardive Dystonia With Second-Generation Antipsychotics in Non-Elderly Schizophrenic Patients Unexposed to First-Generation AntipsychoticsJournal of Clinical Psychopharmacology, Vol. 35, No. 1Acute Dystonia, Akathisia, and Parkinsonism Induced by ZiprasidoneAmerican Journal of Therapeutics, Vol. 21, No. 2Advances in Medicine, Vol. 2014Paediatrics & Child Health, Vol. 17, No. suppl_B, Vol. 100, Vol. 100The tardive syndromesPaediatrics & Child Health, Vol. 16, No. 9Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, Vol. 21, No. 3Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 34, No. 1Vocal Tics Associated With ZiprasidoneJournal of Clinical Psychopharmacology, Vol. 29, No. 6Ziprasidone-related oculogyric crisis in an adultClinical Neurology and Neurosurgery, Vol. 111, No. 10Motor side effects of atypical antipsychotic drugsTherapy, Vol. 6, No. 2The World Journal of Biological Psychiatry, Vol. 10, No. 1Tardive Dystonia Associated With Low-Dose of AmisulprideJournal of Clinical Psychopharmacology, Vol. 28, No. 5Transient Tardive Dystonia: Overview and Case PresentationJournal of Psychiatric Practice, Vol. 14, No. 4General Hospital Psychiatry, Vol. 30, No. 3The Tardive SyndromesProgress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 31, No. 2Tardive dyskinesia in geriatric patientsAging Health, Vol. 2, No. 5Safety of Long-Term Benzodiazepine Therapy; Topiramate and Reversible Anorgasmia; Lymphadenitis and Phenytoin-Induced Hypersensitvity; Syndrome Seeing Double with Your Antidepressant?; Cabergoline and Heart Valve Pathology; Toxicity with Rectal Fentanyl; Tardive Dystonia with Ziprasidone; Prescription of Teratogenic Medications in the US20 July 2017 | Hospital Pharmacy, Vol. 41, No. 2Pharmacoepidemiology and Drug Safety, Vol. 15, No. 5 Volume 162Issue 11 November 2005Pages 2191-2191 Metrics PDF download History Published online 1 November 2005 Published in print 1 November 2005
Publication Year: 2005
Publication Date: 2005-11-01
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 28
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot